NRobotics Co

NRobotics Co Capital Expenditures

The Capital Expenditures (CapEx) of NRobotics Co (138360.KQ) as of Oct 24, 2026 is -60.54 M KRW. In the previous year, Capital Expenditures (CapEx) was -201.28 M KRW — a change of -69.92% (higher).

Capital Expenditures

-60.54 MKRW

YoY

-69.92%

Last updated:

Capital Expenditures (CapEx) of NRobotics Co is 2025 -60.54 M KRW. Capital Expenditures (CapEx) of NRobotics Co was 2024 -201.28 M KRW. It decreases by -69.92% higher compared to the previous year.

The NRobotics Co Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-3.91 B KRW
Jan 1, 2019
-64.70 M KRW
Jan 1, 2020
-485.81 M KRW
Jan 1, 2021
-307.30 M KRW
Jan 1, 2022
-298.55 M KRW
Jan 1, 2023
-585.58 M KRW
Jan 1, 2024
-201.28 M KRW
Jan 1, 2025
-60.54 M KRW
The NRobotics Co Capital Expenditures history
YEARCapital ExpendituresYoY
-60.54 MKRW-69.92%
-201.28 MKRW-65.63%
-585.58 MKRW+96.14%
-298.55 MKRW-2.85%
-307.30 MKRW-36.74%
-485.81 MKRW+650.87%
-64.70 MKRW-98.34%
-3.91 BKRW-64.01%
-10.86 BKRW+649.25%
-1.45 BKRW-80.10%
-7.28 BKRW+101.42%
-3.62 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NRobotics Co Stock analysis

What does NRobotics Co do? Hyupjin Co., Ltd. generates revenue through the manufacture and sale of cosmetic ingredients, including bioconversion technology products, encapsulated products, natural extracts, and synthetic products. Key products such as Aquatouch L, Silkytouch L, Phytoact Reliefer, PhytoAct CosyPlex, Actosome InoCeramide E06, Actosome Retinol850, Actosome Retinal Palmitate, Actostem GinElixir, and Actosome Deage are sold to clients in the cosmetics industry. The company provides electronic materials as part of its product portfolio, targeting manufacturers seeking high-quality cosmetic ingredients and materials for their formulations. Hyupjin Co., Ltd. focuses on delivering specialized cosmetic ingredients through its range of products, with each product composed of specific ingredients like glycerin, dimethicone, water, lecithin, and various plant extracts. The company’s offerings cater to the needs of cosmetic manufacturers who require advanced formulations for skincare and beauty products. Its product lineup includes both natural and synthetic options, supporting diverse applications in the beauty sector. The company’s product portfolio includes Aquatouch L, Silkytouch L, and multiple Actosome series products, all designed to meet the demands of cosmetic manufacturers. These products are formulated with ingredients such as phaseolus radiates seed extract, avena sativa meal extract, and ethyhexylglycerin, among others. Hyupjin Co., Ltd. serves the cosmetics industry by providing ingredients that enhance product performance and consumer appeal, leveraging its bioconversion technology and natural extract expertise. NRobotics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NRobotics Co stock

Capital Expenditures (CapEx) of NRobotics Co is -60.54 M KRW in 2025.

Capital Expenditures (CapEx) of NRobotics Co changed from -201.28 M KRW to -60.54 M KRW, representing a -69.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) NRobotics Co since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s NRobotics Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — NRobotics Co

All Key Metrics — NRobotics Co